LF
Leila Fotooh Abadi
UTsouthwestern medical center, UTSW Medical center, National AIDS Research Institute, David Geffen School of Medicine, University of California, Los Angeles
Research areas: Medicine · Infectious Diseases · Nanoparticle-Based Drug Delivery · HIV/AIDS drug development and treatment · Atherosclerosis and Cardiovascular Diseases
0000-0002-6549-4043
Employment
-
UTsouthwestern medical center Postdoctoral research scholar2023 - Present
-
David Geffen School of Medicine, University of California, Los Angeles Postdoctoral research scholar2023 - 2023
-
UTSW Medical center
Education
- 2014 - 2022
Projects & Funding
-
Assessment of transmigration of nanoparticles across human blood–brain barrier model. European Molecular Biology Organization2020 - 2021
-
AIDS2018 International AIDS Society2018 - Present
-
Fellowship award National AIDS Control Organization, Division of the Ministry of Health and Family Welfare, Government of India2017 - Present
Publications (18)
- Cannabis Is Associated With Potentially Proatherogenic Inflammation in Youth Save
- Inhaled combusted cannabis use is associated with proatherogenic changes in young people: A cross-sectional study Save
- Atherogenic Effects of Acute Electronic Cigarette Compared With Tobacco Cigarette Smoking in People Living With HIV: A Randomized Crossover Trial Save
- Single-Cell Profiling of the Differential In Vivo Impact of Severe Acute Respiratory Syndrome Coronavirus 2 Infection Among Lung Tissue Cell Subtypes at the Protein Level Save
- The Role of the NRF2 Pathway in the Pathogenesis of Viral Respiratory Infections Save
- Severe Acute Respiratory Syndrome Coronavirus 2 Infection Alters Mediators of Lung Tissue Remodeling In Vitro and In Vivo Save
- Tenofovir alafenamide fumarate loaded long-acting microsphere for HIV pre-exposure prophylaxis Save
- HIV-1 exploits Hes-1 expression during pre-existing HPV-16 infection for cancer progression Save
- Tenofovir-tethered gold nanoparticles as a novel multifunctional long-acting anti-HIV therapy to overcome deficient drug delivery-: an in vivo proof of concept Save
- Mannose-Anchored Nano-Selenium Loaded Nanostructured Lipid Carriers of Etravirine for Delivery to HIV Reservoirs Save
- Novel Nanotechnology-Based Approaches for Targeting HIV Reservoirs Save
- Dual loaded nanostructured lipid carrier of nano-selenium and Etravirine as a potential anti-HIV therapy Save
- Multi-organ targeting of HIV-1 viral reservoirs with etravirine loaded nanostructured lipid carrier: An in-vivo proof of concept Save
- Non-nuke HIV-1 inhibitor shuttled by mesoporous silica nanoparticles effectively slows down HIV-1 replication in infected human cells Save
- Abstracts from the International Science Symposium on HIV and Infectious Diseases (ISSHID 2019): Infectious diseases Save
- Design, Synthesis and In Vitro Evaluation of Novel Anti-HIV 3-Pyrazol-3- yl-Pyridin-2-One Analogs Save
- Synthesis and in–vitro anti–HIV–1 evaluation of novel pyrazolo[4,3–c]pyridin–4–one derivatives Save
- Synthesis and Biological Evaluation of 8-Hydroxyquinoline-hydrazones for Anti-HIV-1 and Anticancer Potential Save